Drug intelligence / Profile preview

konjac glucomannan + inulin

Development stage
Preclinical
Modality
Small Molecules, Microbiome Therapeutics
Administration
Oral
01

Overview

Konjac glucomannan + inulin is a combination of two plant-based polysaccharides with prebiotic properties, commonly used as a dietary supplement to promote gut health and metabolic balance. Konjac glucomannan (KGM), derived from the tuber of Amorphophallus konjac, is a water-soluble polysaccharide primarily composed of β-1,4-linked D-glucose and D-mannose units, and is known for its high viscosity and ability to form gels. Inulin, typically extracted from chicory root (Cichorium intybus), is a fructan composed mainly of β-2,1-linked fructose units with a terminal glucose moiety. When consumed together, these fibers exhibit synergistic effects on gut microbiota, mucosal barrier function, and immune modulation via enhancement of short-chain fatty acid production and normalization of tight junction protein expression. Animal studies and limited clinical observations indicate that the combination reduces blood glucose more effectively than either component alone and mitigates colitis and mucosal barrier dysfunction, likely by prebiotic effects that positively modulate the intestinal microbiota, improve tight junction integrity, and exert anti-inflammatory actions. This combination is investigated primarily for its effects on metabolic diseases (notably diabetes and hyperlipidemia), obesity, and inflammatory bowel diseases, but is not classified or regulated as a pharmaceutical drug.

Other names
konjac and inulinKGM + inulinKI compositionkonjac glucomannan and inulinKGM + I

Beyond the preview

Go deeper on konjac glucomannan + inulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on konjac glucomannan + inulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call